Unexpected findings in patients with limbic encephalitis will change disease diagnosis and classification

Jun 27, 2010

New findings indicate that the target of autoantibodies that are associated with limbic encephalitis is LGI1 - a protein involved in fine-tuning of neuronal synapses. The results suggest that testing for these antibodies to LGI1 is diagnostic for limbic encephalitis, and mean that the current classification of the disease should be changed, concludes an Article published Online First and in the August edition of The Lancet Neurology.

Autoimmune synaptic encephalopathies are neurological disorders in which patients develop against proteins on neuronal synapses. Patients present with seizures and neuropsychiatric symptoms, such as psychosis and changes in memory, cognition, and behaviour. Such symptoms are common in patients with limbic encephalitis, an autoimmune synaptic encephalopathy previously attributed to autoantibodies against voltage-gated potassium channels.

A team lead by Josep Dalmau, University of Pennsylvania, Philadelphia, PA, USA, failed to replicate the indirect evidence on autoantibodies against voltage-gated potassium channels in limbic encephalitis so they then sought to find the true target of autoantibodies - known as the autoantigen. Blood or cerebro-spinal fluid (CSF) samples were taken from 57 patients who met criteria for limbic encephalitis and had antibodies attributed to voltage-gated potassium channels (VGKC) and compared with 148 control individuals with other neurological disorders. Most patients received , and 78% had substantial clinical recovery.

The US and Spanish researchers used the establishedapproach used to identify autoimmune synaptic encephalopathies, involving key steps of: using patients' antibodies to precipitate the targeted proteins and then using other biochemical techniques to identify the autoantigen; immunologic staining to show that cell cultures expressing the autoantigen react with patients' but not controls' samples; demonstrating that this reactivity is abrogated by prior exposure to cells expressing the autoantigen; and showing that reactivity to patients' samples occurs in wild-type mice but not in those genetically engineered to lack the mouse equivalent of the autoantigen.

To the surprise of the research team, all patients tested had antibodies against LGI1 (Leucine-rich, glioma-inactivated 1 protein), but not to potassium channels. LGI1 may connect pre- and post-synaptic protein complexes for finely tuned synaptic transmission.

These findings set up the basis for a new, reliable diagnostic test to confirm clinical and brain scan findings in limbic encephalitis, say the authors, who also postulate a mechanism for the disorder. "We speculate that antibody-mediated disruption of LGI1 function causes increased excitability resulting in seizures and other symptoms of limbic encephalopathy," say Dalmau and colleagues. The findings suggest a new diagnostic classification: "the term 'limbic encephalitis associated with VGKC antibodies' should be changed for 'limbic encephalitis associated with LGI1 antibodies'", the authors recommend. Also: "We propose to include this disorder in the "autoimmune synaptic encephalopathies", they explain. Finally, the existence of a disorder related to autoantibodies against voltage-gated remains to be confirmed.

In an accompanying Comment, Jérôme Honnorat, Hôpital Neurologique Pierre Wertheimer, Bron Cedex, France, says: "The identification of LGI1 as the main target of voltage-gated potassium channel antibodies in patients with limbic encephalitis has many consequences for the understanding of the mechanisms that cause the main symptoms in this disease". He explains that LGI1 "is probably a key protein of synaptic organisation and thus the understanding of other neurological disorders might also improve because of these findings" and could lead to new therapeutic strategies for epilepsy, mood disorders, or even neurodegenerative diseases, such as Alzheimer's disease.

Explore further: Study helps explain why elderly have trouble sleeping

add to favorites email to friend print save as pdf

Related Stories

Potatoes may hold key to Alzheimer's treatment

Aug 15, 2008

A virus that commonly infects potatoes bears a striking resemblance to one of the key proteins implicated in Alzheimer's disease (AD), and researchers have used that to develop antibodies that may slow or prevent the onset ...

Decrease in sense of smell seen in lupus patients

Apr 30, 2009

The sense of smell is a complex process of the central nervous system that involves specific areas of the brain. In fact, olfactory dysfunction is seen in various central nervous system disorders that involve immune-mediated ...

Autoantibodies and neuropsychiatric events in lupus

Feb 28, 2008

Systemic lupus erythematosus (SLE), commonly known as lupus, can affect nearly any part of the body, including the joints, skin, kidneys, heart, nervous system, and brain. Along with joint pain, muscle pain, unexplained ...

Study reports success in treating a rare retinal disorder

Apr 13, 2009

Patients with a rare, blinding eye disease saw their vision improve after treatment with drugs to suppress their immune systems, according to researchers at the University of Michigan Kellogg Eye Center. Because autoimmune ...

Recommended for you

Common infections tied to some stroke risk in kids

7 hours ago

A new study suggests that colds and other minor infections may temporarily increase stroke risk in children. The study found that the risk of stroke was increased only within a three-day period between a ...

Celebrities in 'Ice Bucket Challenge' to fight disease

18 hours ago

Steven Spielberg, Justin Bieber and Bill Gates are among many celebrities pouring buckets of ice water over their heads and donating to fight Lou Gehrig's disease, in a fundraising effort that has gone viral.

Study helps explain why elderly have trouble sleeping

19 hours ago

As people grow older, they often have difficulty falling asleep and staying asleep, and tend to awaken too early in the morning. In individuals with Alzheimer's disease, this common and troubling symptom ...

Targeted brain training may help you multitask better

21 hours ago

The area of the brain involved in multitasking and ways to train it have been identified by a research team at the IUGM Institut universitaire de gériatrie de Montréal and the University of Montreal.

User comments : 0